BioMedTech Horizons 2.0

KEY DATES
15 June 2019 - Scheme opens. Submit Notice of Intent (NOI) -ASAP
15 July 2019 (5.00 pm AEST) - Final application deadline

Please note that if participating as a non-lead partner you must submit an NOI and inform your respective School/Department

SUPPORT
View supporting documents from the UoM MRFF Initiatives team.
Relevant documents including the guidelines and online application form can be found on the MTPConnect website

For support, email MRFF Project Officer Catherine Nobes at catherine.nobes@unimelb.edu.au; Tel: 03 83441471

OVERVIEW
The BioMedTech Horizons opportunity will offer $1 million of funding over a maximum two-year period to progress medical technologies and devices through to Proof of Concept or beyond, the point where they are attractive to secure further venture capital or other funding.

Applications consist of a two-stage process: Stage 1 is submission of an EOI and independent multisector review and scoring, following which successful EOI applicants are invited to submit a Stage 2 application.
This current call is for the Stage 1 Non-Confidential Expressions of Interest.

THE GRANT OPPORTUNITY
This is the 2nd round of the BioMedTech Horizons opportunity.
Total pool: To be confirmed (the first round funded 11 projects with $10 million dollars of funding)
Total request: Up to $1 million
Project duration: Up to 2 years

Outcomes of Stage 1 EOI expected by 30 September 2019

ELIGIBILITY
Applications are submitted via a online application form. To be eligible applications must:
1. Identify novel biomedical and medical technology innovations that target one of the specified Clinical Challenges and Therapeutic Areas
2. Come from an Australia based SME (firms or industry which employ up to 200 staff) including startup companies (a University or Research Organisation cannot be the lead applicant).
3. Stimulate collaboration across disciplines and between the research, industry, and technology sectors. Applicant’s research collaborator must be an Australian research organisation/institute/university;
4. Conduct research or related activities in Australia. Critical activities that cannot be undertaken in Australia will be considered on a case by case basis by MTPConnect.
5. Demonstrate an ability to achieve commercial Proof of Concept (i.e. establishing commercial viability of a new product, process etc.) within a two-year period, positioning the program for future investment.
6. Meet expected agreement, terms and conditions and administrative requirements (see guidelines for full criteria)